Cited by 139Neuroendocrine regulation and behaviorAutism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Oxytocin and experimental therapeutics in autism spectrum disorders

BARTZ, J, HOLLANDER, E·2008·Progress in Brain Research

Abstract

Autism is a developmental disorder characterized by three core symptom domains: speech and communication abnormalities, social functioning impairments and repetitive behaviours and restricted interests. Oxytocin (OXT) is a nine-amino-acid peptide that is synthesized in the paraventricular and supraoptic nucleus of the hypothalamus and released into the bloodstream by axon terminals in the posterior pituitary where it plays an important role in facilitating uterine contractions during parturition and in milk let-down. In addition, OXT and the structurally similar peptide arginine vasopressin (AVP) are released within the brain where they play a key role in regulating affiliative behaviours, including sexual behaviour, mother-infant and adult-adult pair-bond formation and social memory/recognition. Finally, OXT has been implicated in repetitive behaviours and stress reactivity. Given that OXT is involved in the regulation of repetitive and affiliative behaviours, and that these are key features of autism, it is believed that OXT may play a role in autism and that OXT may be an effective treatment for these two core symptom domains. In this chapter we review evidence to date supporting a relationship between OXT and autism; we then discuss research looking at the functional role of OXT in autism, as well as a pilot study investigating the therapeutic efficacy of OXT in treating core autism symptom domains. Finally, we conclude with a discussion of directions for future research.

Integrity signals

Registry

Crossref · 10.1016/s0079-6123(08)00435-4

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Animal model research points to a strong relationship between socially monogamous attachment behaviors and the expression of oxytocin within the brain, along with vasopressin and dopamine.

    “Animal model research points to a strong relationship between socially monogamous attachment behaviors and the expression of oxytocin within the brain—along with that of an affiliated peptide, vasopressin, and a suite of auxiliary hormones and neurotransmitters including dopamine.”
  • Implanting a vasopressin receptor gene into the ventral forebrain of typically promiscuous male voles caused them to behave much like their monogamous cousins.

    “In one study, implanting a vasopressin receptor gene into the ventral forebrain of a sample of typically promiscuous male voles caused them to behave much like their monogamous cousins [36]”
  • Intranasal oxytocin may reduce repetitive behaviors and increase performance on social recognition tasks.

    “Intranasal administration of oxytocin may reduce repetitive behaviors, and increase performance on tasks of social recognition [171].”
  • Oxytocin is emerging as a pharmacological target for social dysfunction in clinical trials.

    “oxytocin is emerging as a pharmacological target for social dysfunction in clinical trials (29, 30).”

The citation lists haven’t been fetched yet

References 80 · Cited by 139

Authors
BARTZ, J., & HOLLANDER, E.
Affiliations
Icahn School of Medicine at Mount Sinai (US)
Corresponding author
BARTZ, J
Venue
Progress in Brain Research
Publisher
Elsevier
Published
2008
Volume
170
Pages
451-462
ISSN
0079-6123 (ISSN-L)
OpenAlex
W1557461627
Cited by
139
References
80
Citations by year
2024: 1 · 2023: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 15 · 2014: 11 · 2013: 21 · 2012: 21
FWCI
35.06
Type
book chapter
Language
en
Open access
closed
Locations
  • Progress in brain research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Beatrice and Samuel A. Seaver Foundation
  • National Institutes of Health
  • National Institute of Mental Health (U54MH066673)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
oxytocin, autism spectrum disorder, vasopressin, affiliative behavior, social memory, repetitive behavior, social functioning, oxytocin therapy, hypothalamic neuropeptides, pair bonding, stress reactivity
MeSH terms
Affect, Animals, Autistic Disorder, Cognition, Communication, Disease Models, Animal, Female, Humans, Mother-Child Relations, Obsessive-Compulsive Disorder, Oxytocin, Paraventricular Hypothalamic Nucleus, Pregnancy, Cumulative Trauma Disorders, Social Behavior, Speech Disorders, Supraoptic Nucleus, Uterine Contraction, Parturition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review